Related Experiment Video
Updated: May 28, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Interstitial Fibrosis Severity Is Not Independently Associated with Anemia in Biopsy-Proven Primary
Egemen Cebeci1, Kenan Turgutalp2, Savaş Öztürk3
1Division of Nephrology, Istanbul Haseki Training and Research Hospital, University of Health Sciences, 34260 Istanbul, Türkiye.
Insights
Interstitial fibrosis (IF) severity does not independently predict anemia in primary glomerulonephritis (PGN). Anemia in PGN patients is linked to reduced kidney function, not solely fibrosis extent.
Area of Science:
- Nephrology
- Internal Medicine
- Pathology
Background:
- Anemia is a common complication of chronic kidney disease (CKD).
- Erythropoietin deficiency is the primary cause, but interstitial fibrosis (IF) may also contribute.
- Data on IF's role in anemia within primary glomerulonephritis (PGN) are limited.
Purpose of the Study:
- To investigate the independent association between interstitial fibrosis severity and anemia in patients with biopsy-proven PGN.
- To assess the modifying effect of estimated glomerular filtration rate (eGFR) on the IF-anemia relationship.
Main Methods:
- Nationwide multicenter registry analysis (TSN-GOLD) of 2794 adults with PGN.
- Interstitial fibrosis graded semi-quantitatively; anemia defined by KDIGO/WHO criteria.
- Multivariable logistic regression and interaction analysis (IF×eGFR) were performed.
Main Results:
- Anemia was present in 34.4% of patients.
- Interstitial fibrosis severity was not independently associated with anemia (p-trend = 0.72).
- Female sex and lower eGFR were independently associated with anemia; a significant IF×eGFR interaction was observed (p = 0.0029).
Conclusions:
- Interstitial fibrosis severity is not an independent predictor of anemia in PGN patients.
- The relationship between IF and anemia in PGN is primarily mediated by renal functional status (eGFR).
- Further research should consider renal function when evaluating fibrosis-related anemia in PGN.
Abstract:
Background and Objectives: Anemia is a frequent complication of chronic kidney disease (CKD), primarily attributed to erythropoietin deficiency. Interstitial fibrosis (IF), which disrupts the renal interstitium where erythropoietin-producing cells reside, may contribute to anemia independent of glomerular filtration rate (GFR). However, data in primary glomerulonephritis (PGN) are limited and conflicting. Materials and Methods: In this nationwide multicenter registry analysis (TSN-GOLD), 2794 adults with biopsy-proven PGN were included. Interstitial fibrosis was graded semi quantitatively (0-3). Anemia was defined according to KDIGO/WHO criteria. Multivariable logistic regression models were constructed to evaluate the independent association between IF severity and anemia, adjusting for age, sex, eGFR, log-transformed proteinuria, hypertension, diabetes mellitus, and biopsy diagnosis. Interaction between IF and eGFR was assessed. A predefined subgroup analysis was performed in patients with preserved renal function (eGFR ≥ 60 mL/min/1.73 m2). Results: Anemia was present in 34.4% of patients. Although moderate-to-severe IF was more frequent among anemic patients (p < 0.001), IF severity was not independently associated with anemia in multivariable analysis (p-trend = 0.72). Female sex and lower eGFR were independently associated with anemia. A statistically significant IF×eGFR interaction was observed (p = 0.0029), indicating effect modification across renal function levels. The model demonstrated moderate discrimination (AUC = 0.705). In patients with preserved renal function, IF severity was not associated with anemia. Conclusions: In this large multicenter cohort of PGN patients, interstitial fibrosis severity was not independently associated with anemia after adjustment for renal function and clinical covariates. These findings suggest that the association between interstitial fibrosis and anemia in PGN appears largely mediated by renal functional status rather than fibrosis severity alone.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management